NY-ESO-1 Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer (NCT03240861) | Jonsson Comprehensive Cancer Center | 2017-07-26 |
Track NY-ESO-1 Positive automatically
Every clearance here is in the API, with alerts when new ones post.